Kern Capital

Kern Capital manages a diversified portfolio stretching from new ventures to established and profitable businesses across many industry sectors, but with a particular focus on the life sciences. We tend to make investments of $5 to $15 million in only a few companies each year, and partner with outstanding management teams for the long term. While we typically are active members of the board of directors of our portfolio businesses, we do not seek involvement in their daily operations. Through a long-term approach to the liquidity horizon, Kern Capital investments are not beholden to a single exit strategy, but are instead opportunistic about investor capital return whether through M&A, IPO, recap, dividend, or otherwise. Our Mission is to provide capital and advice to help entrepreneurs realize their dreams of creating market-leading businesses. Nothing gives us greater satisfaction than to see those dreams fulfilled. What We Look For We back strong management teams in companies that have the potential to become market-leading businesses within their sector niche. While we have a particular focus in the life sciences, we remain opportunistic investors, and will not rule out any opportunity with the potential for capital-efficient growth and attractive profit margins. Typically, we invest from $5 to $15 million in post-seed financing rounds and have led rounds from Series A all the way through the final round prior to IPO or sale. We will also consider the acquisition of an established business. We prefer simple capital structures so that our interests are more closely aligned with management.